What is the typical course of Macrobid (nitrofurantoin monohydrate) for an uncomplicated urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Macrobid Course for Uncomplicated UTI

For uncomplicated cystitis in women, prescribe nitrofurantoin monohydrate/macrocrystals (Macrobid) 100 mg twice daily for 5 days. 1, 2

Standard Dosing Regimen

  • Nitrofurantoin monohydrate/macrocrystals (Macrobid): 100 mg orally twice daily for 5 days is the guideline-recommended first-line therapy for uncomplicated UTI in women 1, 2
  • The 5-day regimen achieves clinical cure rates of 88-93% and bacterial cure rates of 81-92% 2
  • This formulation allows twice-daily dosing due to its dual-release properties, improving compliance compared to older formulations requiring four-times-daily dosing 3

When to Extend Duration

  • Consider 7 days of therapy if symptoms persist at day 5 or in specific clinical scenarios where treatment response may be slower 2, 4
  • The American College of Physicians and IDSA guidelines support 5-7 day courses, with 5 days being optimal for most uncomplicated cases 1, 2

Special Dosing Situations

  • For enterococcal UTIs (including VRE): Use 100 mg four times daily (every 6 hours) rather than twice daily 2, 3
  • For men with uncomplicated UTI: Limited data support 7-14 days of therapy, though specific evidence is sparse 4
  • For children ≥12 years: 100 mg twice daily; for children <12 years: 5-7 mg/kg/day divided into 4 doses (maximum 100 mg/dose) for 7 days 2

Critical Contraindications

  • Do not use if creatinine clearance <60 mL/min 3
  • Avoid if early pyelonephritis is suspected - nitrofurantoin does not achieve adequate tissue concentrations for upper tract infections 2
  • Contraindicated in last trimester of pregnancy 3

Comparison to Alternative First-Line Agents

The 5-day nitrofurantoin regimen is equivalent in efficacy to:

  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (90% clinical cure for both) 2
  • Ciprofloxacin 7-day regimens (95% cure rate), though fluoroquinolones should be reserved for more invasive infections 2, 4

Nitrofurantoin maintains a resistance rate of only 2.3% compared to 24% for fluoroquinolones and 29% for trimethoprim-sulfamethoxazole, making it an excellent fluoroquinolone-sparing option 5

Common Pitfalls to Avoid

  • Do not prescribe for pyelonephritis or perinephric abscess - inadequate tissue penetration 2
  • Do not extend beyond 7 days for uncomplicated cystitis unless symptoms persist, as longer courses increase adverse effects without improving efficacy 2
  • Do not use in patients with renal impairment (CrCl <60 mL/min) due to risk of accumulation and serious adverse effects including pulmonary reactions and polyneuropathy 3
  • Common side effects include nausea and headache (5.6-34% adverse event rate), which patients should be counseled about 2, 3

Follow-Up Recommendations

  • Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 2
  • If symptoms do not resolve by end of treatment or recur within 2 weeks: Obtain urine culture with susceptibility testing and consider retreatment with a 7-day regimen using another agent 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Formulations for Uncomplicated UTIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.